Answers are grounded in this paper and cite their sources.
Evaluates rice-derived legumain inhibitor's effect on tumor cell migration and viability, suggesting cancer treatment potential.
The cystatin superfamily includes proteins crucial for inhibiting cysteine proteases, enzymes involved in many biological processes. In plants, cystatins regulate seed germination, development, and pathogen defense. In humans, inhibiting legumain-type cysteine proteases offers a promising cancer treatment strategy, as this enzyme's expression often rises during tumor progression. We evaluated a novel rice-derived chimeric legumain inhibitor using in silico and in vitro methods. Computational simulations confirmed the inhibitor's stability and nanomolar affinity for legumain's active site. Post-expression and purification assays determined its kinetics and demonstrated its efficacy in reducing HT29 tumor cell migration and viability. Our findings suggest the chimeric Oryzacystatin I mutant with SNSL motifs is a promising candidate for cancer drug development.
No takes yet. Share an insight, caveat, or question.
Dias-Oliveira et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: